Medicare Bill Contains Significant Changes for Drug Manufacturers

January 2, 2004
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-01-02-2004, Volume 28, Issue 1

The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.